CATALOGO DEI PRODOTTI DELLA RICERCA

DONADELLI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.323
EU - Europa 3.020
AS - Asia 1.134
SA - Sud America 13
OC - Oceania 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.300
GB - Regno Unito 1.152
CN - Cina 815
IT - Italia 453
FR - Francia 269
SE - Svezia 264
IE - Irlanda 235
DE - Germania 178
RU - Federazione Russa 169
FI - Finlandia 150
SG - Singapore 103
VN - Vietnam 85
UA - Ucraina 61
TR - Turchia 38
BE - Belgio 35
KR - Corea 27
CA - Canada 22
ES - Italia 15
IR - Iran 14
IN - India 13
JP - Giappone 13
NL - Olanda 13
AU - Australia 6
SA - Arabia Saudita 5
BR - Brasile 4
HK - Hong Kong 4
PL - Polonia 4
CH - Svizzera 3
CL - Cile 3
ID - Indonesia 3
MM - Myanmar 3
RO - Romania 3
BO - Bolivia 2
CO - Colombia 2
IL - Israele 2
KG - Kirghizistan 2
MY - Malesia 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NG - Nigeria 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
Totale 7.499
Salva come PNG Salva come JPEG
Città #
Southend 1.082
Chandler 676
Jacksonville 360
Woodbridge 328
Ann Arbor 301
Dublin 233
Verona 192
Beijing 168
Ashburn 149
New York 146
Houston 141
Lawrence 93
Princeton 93
Wilmington 89
Nanjing 73
Jinan 70
Redmond 70
Singapore 62
Shenyang 61
Hebei 48
Dong Ket 45
Helsinki 44
Phoenix 44
Tianjin 42
Redwood City 34
Changsha 33
Sindelfingen 33
Brussels 32
Haikou 30
Venice 30
Zhengzhou 29
Nanchang 28
Seoul 26
Düsseldorf 24
Ningbo 22
Boardman 21
Norwalk 21
Dallas 20
Jiaxing 20
Hangzhou 19
Kent 17
Seattle 17
Taizhou 16
Milan 15
Guangzhou 13
Taiyuan 13
Caserta 12
Augusta 11
Tokyo 11
Washington 11
Toronto 10
Auburn Hills 9
Falls Church 9
Fuzhou 9
Madrid 9
San Francisco 8
Dearborn 7
Mestre 7
Ardabil 6
Lanzhou 6
San Mateo 6
Chions 5
Clearwater 5
Fairfield 5
Lappeenranta 5
Leawood 5
Monmouth Junction 5
Montréal 5
Mumbai 5
San Giovanni Ilarione 5
Bologna 4
Cambridge 4
Chicago 4
Cleveland 4
Riyadh 4
San Diego 4
Boydton 3
Can Tho 3
Edinburgh 3
Elora 3
Ghent 3
Groningen 3
Hanoi 3
Hong Kong 3
Kemerovo 3
London 3
Los Angeles 3
Nürnberg 3
Poggio Rusco 3
Rome 3
San Jose 3
Tombolo 3
Yangon 3
Aarau 2
Amsterdam 2
Andover 2
Bishkek 2
Bratislava 2
Caerano di San Marco 2
Canberra 2
Totale 5.388
Salva come PNG Salva come JPEG
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 216
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 160
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 136
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 134
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 131
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 125
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 121
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 121
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 118
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 116
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 114
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 112
Cytotoxicity of Polyspermine-Ribonuclease A and Polyspermine-Dimeric Ribonuclease A 111
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 111
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 108
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 106
Regulation of miR-23b expression and its dual role on ROS production and tumour development 106
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 104
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 104
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 103
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 102
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 101
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 100
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 99
Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells 98
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 97
Proteomics in pancreatic cancer research. 97
Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner 97
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 96
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 96
Increase of RNase A N-terminus Polarity or C-terminus Apolarity Changes the Two Domains' Propensity To Swap and Form the Two Dimeric Conformers of the Protein 91
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 89
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 89
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 87
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 86
Double Domain Swapping in Bovine Seminal RNase: Formation of Distinct N- and C-swapped Tetramers and Multimers with Increasing Biological Activities 86
The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition 86
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 85
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 82
The metabolic landscape of cancer stem cells 82
Regulation of catalase expression in chronic lymphocytic leukemia cells. 82
UCP2, a mitochondrial protein regulated at multiple levels 80
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells 79
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 78
The antioxidant mitochondrial protein UCP2 promotes cancer development connecting theWarburg effect and autophagy 78
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 77
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 75
Mutant p53 and mTOR/PKM2 regulation in cancer cells 75
Targeting survival signaling pathways in chronic lymphocytic leukemia via anti-CD20 antibodies 75
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 74
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 74
Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells 73
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 72
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: involvement in cancer invasion and metastasis 72
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 71
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 71
Oncometabolites in cancer aggressiveness and tumour repopulation 68
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells 68
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 68
Molecular interplay between mutant p53 proteins and autophagy in cancer cells 66
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 65
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 65
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 64
Rehabilitation and biomarkers of stroke recovery: study protocol for a randomized controlled trial 64
Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer 64
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 63
Cell communication and signaling: how to turn bad language into positive one 63
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 62
Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: an in depth proteomic study 61
Autocrine mechanisms of cancer chemoresistance 59
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 58
The cancer secretome and secreted biomarkers 54
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 53
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 53
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma 51
Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches 50
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease 50
Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC 50
The mutant p53-driven secretome has oncogenic functions in pancreatic ductal adenocarcinoma cells 48
Proteomic Signature of PDAC Cells with Mutant p53 47
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 45
Gut microbiota modulates seizure susceptibility 45
Redox sensitive cysteine residues as crucial regulators of wild-type and mutant p53 isoforms 43
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity 42
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 42
Regulation of succinate dehydrogenase and role of succinate in cancer 41
Reprogramming tumor-immune cell interface in solid and hematological malignancies to enhance response to therapy 40
Sestrins as a therapeutic bridge between ROS and autophagy in cancer 40
From single gene analysis to single cell profiling: a new era for precision medicine 37
3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death 36
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 33
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 33
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons 31
Mitochondrial metabolic alterations in cancer cells and related therapeutic targets 30
Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance 30
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 21
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 20
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells 18
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 17
Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate 16
Totale 7.583
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.039
article - articoli 23.837
book - libri 0
conference - conferenze 2.202
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020701 0 23 27 46 99 95 87 46 58 93 41 86
2020/2021893 130 105 40 79 103 90 33 49 45 10 106 103
2021/2022815 114 200 20 53 21 19 26 52 25 29 71 185
2022/20231.867 121 196 154 364 158 418 23 98 206 61 50 18
2023/2024940 37 56 74 92 116 217 29 78 15 48 132 46
2024/2025226 112 114 0 0 0 0 0 0 0 0 0 0
Totale 7.639